NO882037D0 - Famotidin, polymerte former og fremstilling derav. - Google Patents

Famotidin, polymerte former og fremstilling derav.

Info

Publication number
NO882037D0
NO882037D0 NO882037A NO882037A NO882037D0 NO 882037 D0 NO882037 D0 NO 882037D0 NO 882037 A NO882037 A NO 882037A NO 882037 A NO882037 A NO 882037A NO 882037 D0 NO882037 D0 NO 882037D0
Authority
NO
Norway
Prior art keywords
famotidine
manufacturing
polymeric forms
preparation
melting point
Prior art date
Application number
NO882037A
Other languages
English (en)
Other versions
NO882037L (no
Inventor
Montserrat Ballester-Rodes
Francisco Eugen Palomo-Nicolau
Antonio Luis Palomo-Coll
Original Assignee
Marga Para La Invest Sa Centro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27240404&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO882037(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ES8702020A external-priority patent/ES2009147A6/es
Priority claimed from ES8703326A external-priority patent/ES2015339A6/es
Priority claimed from ES8800888A external-priority patent/ES2017246A6/es
Application filed by Marga Para La Invest Sa Centro filed Critical Marga Para La Invest Sa Centro
Publication of NO882037D0 publication Critical patent/NO882037D0/no
Publication of NO882037L publication Critical patent/NO882037L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Electron Beam Exposure (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NO882037A 1987-06-22 1988-05-10 Famotidin, polymerte former og fremstilling derav. NO882037L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES8702020A ES2009147A6 (es) 1987-06-22 1987-06-22 Nuevo proceso para la preparacion de polimorfos de famotidina
ES8703326A ES2015339A6 (es) 1987-10-29 1987-10-29 Perfeccionamientos a la patente de invencion numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.
ES8800888A ES2017246A6 (es) 1988-03-23 1988-03-23 Mejoras a la patente de invencion, numero 8702020 por nuevo proceso para la preparacion de polimorfos de famotidina.

Publications (2)

Publication Number Publication Date
NO882037D0 true NO882037D0 (no) 1988-05-10
NO882037L NO882037L (no) 1988-12-23

Family

ID=27240404

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882037A NO882037L (no) 1987-06-22 1988-05-10 Famotidin, polymerte former og fremstilling derav.

Country Status (13)

Country Link
US (1) US5021582A (no)
EP (1) EP0297019B1 (no)
JP (1) JPH01100162A (no)
KR (1) KR920000308B1 (no)
CN (1) CN1030077A (no)
AT (1) ATE69052T1 (no)
AU (1) AU1767288A (no)
CA (1) CA1322760C (no)
DE (1) DE3865899D1 (no)
DK (1) DK342988A (no)
FI (1) FI882329A (no)
IL (1) IL86330A0 (no)
NO (1) NO882037L (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances
US5631023A (en) * 1993-07-09 1997-05-20 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
WO1997027191A1 (en) * 1996-06-19 1997-07-31 Dr. Reddy's Research Foundation Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
JP4755789B2 (ja) * 2001-09-26 2011-08-24 株式会社フジシールインターナショナル ラベル及びその製造方法
CA2426122A1 (en) * 2002-05-02 2003-11-02 M/S Tonira Pharma Limited A process for the preparation of a combination of famotidine polymorphis a and b
US8058296B2 (en) * 2008-11-25 2011-11-15 Richard Tokunaga Treatment and prevention of deleterious effects associated with alcohol consumption

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496737A (en) * 1982-09-27 1985-01-29 Merck & Co., Inc. Process for preparing sulfamylamidine antisecretory agents
JPS59227870A (ja) * 1983-06-07 1984-12-21 Yamanouchi Pharmaceut Co Ltd 新規２−グアニジノチアゾリン誘導体ならびにその製造法
HU194845B (en) * 1985-09-11 1988-03-28 Richter Gedeon Vegyeszet Process for production of n-sulphamil-3-/2-guanidintiazolil-4-methil-tio/-propion-amidin
DE3644246A1 (de) * 1986-06-20 1987-12-23 Uriach & Cia Sa J Verfahren zur herstelung von 3-(((2-((aminoiminomethyl)-amino)-4-thiazolyl)-methyl)-thio)-n-(aminosulfonyl)-propanimidamid
HU196775B (en) * 1986-08-05 1989-01-30 Richter Gedeon Vegyeszet Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances

Also Published As

Publication number Publication date
ATE69052T1 (de) 1991-11-15
JPH01100162A (ja) 1989-04-18
FI882329A (fi) 1988-12-23
US5021582A (en) 1991-06-04
KR890000086A (ko) 1989-03-11
EP0297019B1 (en) 1991-10-30
DE3865899D1 (de) 1991-12-05
NO882037L (no) 1988-12-23
CA1322760C (en) 1993-10-05
FI882329A0 (fi) 1988-05-18
KR920000308B1 (ko) 1992-01-11
DK342988A (da) 1988-12-23
DK342988D0 (da) 1988-06-22
CN1030077A (zh) 1989-01-04
EP0297019A1 (en) 1988-12-28
IL86330A0 (en) 1988-11-15
AU1767288A (en) 1988-12-22

Similar Documents

Publication Publication Date Title
IT8522494A0 (it) Procedimento per la preparazione di formulazioni solide di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute.
DE3750431T2 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
DE3883985T2 (de) Ärztliches instrument und dessen herstellung.
ES2099718T3 (es) Analogos de oligonucleotidos con uniones internucleotidicas de 3'-3' o 5'-5' terminales.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
PH22556A (en) Heterocyclic compounds, pharmaceutical compositions containing the same and method of use thereof
DE3876400T2 (de) Aminosaeure-imid-derivate, ihre verwendung und diese enthaltende medizinische zusammensetzungen.
NO853466L (no) Stabilisert, smussfrigjoeringsbefordrende polymer av polyethylenterefthalat og polyoxethylenterefthalat og fremgangsmaate for fremstilling av denne.
LV10381A (lv) Cieto arstniecisko formu iegusanas panemiens un cietas arstnieciskas formas
NO882037D0 (no) Famotidin, polymerte former og fremstilling derav.
DE69112074T2 (de) Disubstituierte arylverbindungen welche eine selektive leukotrien-b4 antagonistische aktivität aufweisen.
IT8321727A0 (it) Procedimento per la fabbricazione di corpi tubolari flessibili, dispositivo per l'attuazione ditale procedimento e corpi flessibili ottenuti.
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
NO870104D0 (no) Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
IT8984980A0 (it) Procedimento per la realizzazione di cingoli in gomma e cingolo cosi'.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
DE69021599T2 (de) Biologisch aktive RON-Substanz Synthetase und ihre Verwendung für die Herstellung biologisch aktiver RON-Substanz.
BG60271B1 (bg) 13-алкил-23-имино и 13-хало-23-имино производни на ll-f28249 и приложението им като ендо- и ектопаразитицидни, инсектицидни, акарицидни и нематоцидни средства
PT87743A (pt) Process for the preparation of pyrimidine derivatives and of insecticide and acaricide compounds which contain them
IT8722553A0 (it) Procedimento per la fabbricazione di corpi tubolari leggeri e corpo tubolare ottenuto tramite detto procedimento.
DE3888697D1 (de) 2,3-thiomorpholinedion-2-oxim-derivate, arzneimittelzusammensetzungen und verfahren zur herstellung.
IT8723035A0 (it) Procedimento per la preparazione di n acilaniline.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
FR2612183B1 (fr) Nouveaux composes chimiques trifluoromethyles et leur procede de preparation
IT8622819A0 (it) Procedimento per la preparazione di composti stabilizzanti e composti stabilizzanti cosi' ottenuti.